Biogen
Trade Biogen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
BIIB News
The Medicines and Healthcare products Regulatory Agency said it has approved Zurzuvae to treat moderate or severe postnatal depression in adults following child...
Biogen Inc. (BIIB) and Stoke Therapeutics (STOK) announced presentations of new clinical data from studies of zorevunersen at the 36th International Epilepsy Co...
Eisai (ESAIY) and Biogen (BIIB) announced that the anti-amyloid beta monoclonal antibody Leqembi has been launched in Austria on August 25 and will be launched...
Analyst ratings
49%
of 35 ratingsMore BIIB News
If you have been tracking Biogen (BIIB) lately, the company’s shares have quietly gained 6% in the past month, recapturing some ground after a tough stretch. Wh...
Biogen Inc. ((BIIB)), Biogen ((CC:HTER)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...
Biogen Inc. ((BIIB)), Biogen ((CC:HTER)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...
Biogen Inc. ((BIIB)), Biogen ((CC:HTER)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...